Annual CFF
$6.20 M
-$26.01 M-80.75%
31 December 2023
Summary:
NRx Pharmaceuticals annual cash flow from financing activities is currently $6.20 million, with the most recent change of -$26.01 million (-80.75%) on 31 December 2023. During the last 3 years, it has risen by +$2.95 million (+90.86%). NRXPW annual CFF is now -90.23% below its all-time high of $63.46 million, reached on 31 December 2021.NRXPW Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$2.05 M
-$1.09 M-34.61%
30 September 2024
Summary:
NRx Pharmaceuticals quarterly cash flow from financing activities is currently $2.05 million, with the most recent change of -$1.09 million (-34.61%) on 30 September 2024. Over the past year, it has increased by +$3.56 million (+236.84%). NRXPW quarterly CFF is now -94.53% below its all-time high of $37.52 million, reached on 30 September 2021.NRXPW Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$4.47 M
+$3.56 M+386.83%
30 September 2024
Summary:
NRx Pharmaceuticals TTM cash flow from financing activities is currently $4.47 million, with the most recent change of +$3.56 million (+386.83%) on 30 September 2024. Over the past year, it has increased by +$5.97 million (+398.07%). NRXPW TTM CFF is now -91.39% below its all-time high of $51.99 million, reached on 30 September 2021.NRXPW TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NRXPW Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -80.8% | +236.8% | +398.1% |
| 3 y3 years | +90.9% | -94.5% | -91.4% |
| 5 y5 years | - | +123.7% | +115.0% |
NRXPW Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -90.2% | +90.9% | -94.5% | +103.2% | -91.4% | +139.1% |
| 5 y | 5 years | -90.2% | +115.7% | -94.5% | +103.2% | -91.4% | +106.8% |
| alltime | all time | -90.2% | +115.7% | -94.5% | +103.2% | -91.4% | +106.8% |
NRx Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.05 M(-34.6%) | $4.47 M(+386.8%) |
| June 2024 | - | $3.14 M(+695.2%) | $919.00 K(-141.4%) |
| Mar 2024 | - | $395.00 K(-135.4%) | -$2.22 M(-15.1%) |
| Dec 2023 | $6.20 M(-80.8%) | -$1.12 M(-25.6%) | -$2.62 M(+74.4%) |
| Sept 2023 | - | -$1.50 M(+74.5%) | -$1.50 M(-60.3%) |
| Dec 2022 | $32.21 M(-49.2%) | - | - |
| June 2022 | - | -$860.00 K(-103.7%) | -$3.78 M(+30.6%) |
| Mar 2022 | - | $22.98 M(-136.2%) | -$2.90 M(-74.7%) |
| Dec 2021 | $63.46 M | -$63.42 M(-269.0%) | -$11.45 M(-122.0%) |
| Sept 2021 | - | $37.52 M(>+9900.0%) | $51.99 M(+227.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | $25.94 K(-99.8%) | $15.89 M(-0.9%) |
| Mar 2021 | - | $14.43 M(>+9900.0%) | $16.04 M(-166.4%) |
| Dec 2020 | $3.25 M(-108.2%) | $19.22 K(-98.6%) | -$24.16 M(-28.4%) |
| Sept 2020 | - | $1.42 M(+722.3%) | -$33.75 M(-23.0%) |
| June 2020 | - | $172.91 K(-100.7%) | -$43.86 M(-33.6%) |
| Mar 2020 | - | -$25.77 M(+169.1%) | -$66.03 M(+67.3%) |
| Dec 2019 | -$39.46 M | -$9.58 M(+10.2%) | -$39.46 M(+32.0%) |
| Sept 2019 | - | -$8.69 M(-60.5%) | -$29.89 M(+41.0%) |
| June 2019 | - | -$22.00 M(-2861.5%) | -$21.20 M(-2761.5%) |
| Mar 2019 | - | $796.64 K | $796.64 K |
FAQ
- What is NRx Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals annual CFF year-on-year change?
- What is NRx Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals quarterly CFF year-on-year change?
- What is NRx Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals TTM CFF year-on-year change?
What is NRx Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of NRXPW is $6.20 M
What is the all time high annual CFF for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high annual cash flow from financing activities is $63.46 M
What is NRx Pharmaceuticals annual CFF year-on-year change?
Over the past year, NRXPW annual cash flow from financing activities has changed by -$26.01 M (-80.75%)
What is NRx Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of NRXPW is $2.05 M
What is the all time high quarterly CFF for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high quarterly cash flow from financing activities is $37.52 M
What is NRx Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, NRXPW quarterly cash flow from financing activities has changed by +$3.56 M (+236.84%)
What is NRx Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of NRXPW is $4.47 M
What is the all time high TTM CFF for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high TTM cash flow from financing activities is $51.99 M
What is NRx Pharmaceuticals TTM CFF year-on-year change?
Over the past year, NRXPW TTM cash flow from financing activities has changed by +$5.97 M (+398.07%)